Point/Nonpoint Source Trading of Pollution Abatement: Choosing the Right Trading Ratio
- 期刊名称American Journal of Agricultural Economics
- 作者Arun S. Malik, David Letson and Stephen R. Crutchfield
- 卷第75卷
- 期第4期
- 印刷ISSN0002-9092
- 电子ISSN1467-8276
- 文件大小792.70KB
- 发表时间1993-11
- DOI10.2307/1243983
- 页码959-967
PainKevin Lee; David Spanswick · 2006
Leading the charge – pioneering treatments in the fight against neuropathic painTracey Dickinson; Kevin Lee; David Spanswick; Fiona E. Munro · 2003
Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleusvan den Top, Marco; Lee, Kevin; Whyment, Andrew D; Blanks, Andrew M; Spanswick, David · 2004
Orexins induce increased Excitability and Synchronisation of Rat Sympathetic Preganglionic NeuronesMarco van den Top; Matthew F. Nolan; Kevin Lee; Peter J. Richardson; Ruud M. Buijs; Ceri H. Davies; David Spanswick · 2003
Histamine Excites Neonatal Rat Sympathetic Preganglionic Neurons In Vitro Via Activation of H <sub/>1</sub> ReceptorsWhyment, Andrew D.; Blanks, Andrew M.; Lee, Kevin; Renaud, Leo P.; Spanswick, David · Journal of Neurophysiology · 2006
Nitric oxide inhibits NMDA currents in a subpopulation of substantia gelatinosa neurons of the adult rat spinal cordRuth Nicholson; David Spanswick; Kevin Lee · 2004
Drugs for insomniaZisapel, Nava · Expert Opinion on Emerging Drugs · 2012
Emerging drugs for asthmaQuirce, Santiago; Bobolea, Irina; Barranco, Pilar · Expert Opinion on Emerging Drugs · 2012
Emerging antiviral drugsClercq, Erik De · Expert Opinion on Emerging Drugs · 2008
Emerging therapies for goutSingh, Jasvinder A · Expert Opinion on Emerging Drugs · 2012
Emerging cognitive enhancing drugsBuccafusco, Jerry J · Expert Opinion on Emerging Drugs · 2009
Emerging drugs for hypogonadismEdelstein, Daniel; Dobs, Adrian; Basaria, Shehzad · Expert Opinion on Emerging Drugs · 2006
Emerging drugs for actinic keratosisUlrich, Martina; Drecoll, Ulrike; Stockfleth, Eggert · Expert Opinion on Emerging Drugs · 2010
Emerging drugs for ovarian cancerKelland, Lloyd R · Expert Opinion on Emerging Drugs · 2005